[
  {
    "variant_id": {
      "Gene": "LRRK2",
      "Protein_Change": {
        "ref": "Gly",
        "alt": "Arg",
        "position": "2385"
      },
      "variant_string_id": "LRRK2 Gly2385Arg"
    },
    "functional_evidence_aim": "Pathogenic",
    "assessment_steps": [
      {
        "step_name": "Step 1: Define the disease mechanism",
        "extracted_paper_info": "The paper clearly defines the disease (Parkinson's disease) mechanism relevant to the functional assay being described for this variant, as it discusses the role of LRRK2 protein and its function within the disease pathogenesis.",
        "judgment": true
      },
      {
        "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
        "extracted_paper_info": "The assay used (cell phenotype rescue assay) effectively models or reflects the disease pathogenesis/mechanism defined in Step 1, as it examines the functional impact of LRRK2 mutations on cell survival and movement.",
        "judgment": true
      },
      {
        "step_name": "Step 3: Evaluate validity of specific instances of assays",
        "sub_steps": [
          {
            "sub_step_name": "3a: Basic Controls and Replicates",
            "questions": [
              {
                "question": "Were basic controls included for this assay? Specifically, were 'Normal/Negative/Wild type' AND 'Abnormal/Positive/Null' controls used?",
                "answer": true
              },
              {
                "question": "Did the paper explicitly state that multiple replicates were used for the experiments?",
                "answer": true
              }
            ],
            "judgment": true
          },
          {
            "sub_step_name": "3b: Accepted/Validated Assay",
            "question": "Has the specific instance of the assay been previously validated in other studies (cited)?",
            "answer": false
          }
        ]
      },
      {
        "step_name": "Step 4: Apply evidence to individual variant interpretation",
        "sub_steps": [
          {
            "sub_step_name": "4a: Statistical Analyses",
            "question": "Are the statistical analyses in the paper sufficient to estimate or calculate OddsPath for the functional data for this variant?",
            "answer": true
          },
          {
            "sub_step_name": "4b: No OddsPath Calculation (if statistical analyses were insufficient)",
            "question": "How many total benign/pathogenic variant controls were used across the entire study (as applicable to this variant's assay)?",
            "answer": 3,
            "judgment": false
          },
          {
            "sub_step_name": "4c: Correlate OddsPath (if statistical analyses were sufficient)",
            "information": "The paper calculates an OddsPath of 2.7 for this variant.",
            "judgment_basis": "Applying ACMG guidelines, an OddsPath of 2.0 and above is considered supporting evidence for pathogenicity.",
            "judgment": true
          }
        ]
      }
    ],
    "overall_conclusion": "The LRRK2 Gly2385Arg variant shows functional evidence in support of its pathogenic role, as indicated by an OddsPath value of 2.7."
  }
]